Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience
ConclusionSeveral clinical parameters differ between SR and NR to prophylactic CGRP(-R) mAbs. A thorough clinical evaluation prior to treatment initiation might help to achieve a more personalized management in patients with migraine.
Source: The Journal of Headache and Pain - Category: Neurology Source Type: research
More News: Chronic Pain | Depression | Headache | Migraine | Neurology | Pain | Pain Management | Study